306 related articles for article (PubMed ID: 21955816)
1. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
[TBL] [Abstract][Full Text] [Related]
4. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
5. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
[TBL] [Abstract][Full Text] [Related]
6. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
[TBL] [Abstract][Full Text] [Related]
7. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
[TBL] [Abstract][Full Text] [Related]
8. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.
Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
Neurobiol Aging; 2011 Aug; 32(8):1379-87. PubMed ID: 19781815
[TBL] [Abstract][Full Text] [Related]
10. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
[TBL] [Abstract][Full Text] [Related]
11. Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.
Lambert JC; Schraen-Maschke S; Richard F; Fievet N; Rouaud O; Berr C; Dartigues JF; Tzourio C; Alpérovitch A; Buée L; Amouyel P
Neurology; 2009 Sep; 73(11):847-53. PubMed ID: 19752451
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.
Lewczuk P; Kornhuber J; Vanmechelen E; Peters O; Heuser I; Maier W; Jessen F; Bürger K; Hampel H; Frölich L; Henn F; Falkai P; Rüther E; Jahn H; Luckhaus Ch; Perneczky R; Schmidtke K; Schröder J; Kessler H; Pantel J; Gertz HJ; Vanderstichele H; de Meyer G; Shapiro F; Wolf S; Bibl M; Wiltfang J
Exp Neurol; 2010 Jun; 223(2):366-70. PubMed ID: 19664622
[TBL] [Abstract][Full Text] [Related]
15. Plasma amyloid β, depression, and dementia in community-dwelling elderly.
Direk N; Schrijvers EM; de Bruijn RF; Mirza S; Hofman A; Ikram MA; Tiemeier H
J Psychiatr Res; 2013 Apr; 47(4):479-85. PubMed ID: 23312759
[TBL] [Abstract][Full Text] [Related]
16. No correlation between time-linked plasma and CSF Abeta levels.
Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
[TBL] [Abstract][Full Text] [Related]
17. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
19. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease.
González-Martínez Á; Rosado B; Pesini P; Suárez ML; Santamarina G; García-Belenguer S; Villegas A; Monleón I; Sarasa M
Exp Gerontol; 2011 Jul; 46(7):590-6. PubMed ID: 21377518
[TBL] [Abstract][Full Text] [Related]
20. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
